Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Nuclear Medicine

  Free Subscription


01.06.2026

5 Ann Nucl Med
1 Appl Radiat Isot
1 J Nucl Cardiol
4 J Nucl Med
2 Lancet
4 Nucl Med Commun
1 Phys Med Biol
1 Semin Nucl Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Nucl Med

  1. OZBEK RD, Aytekin A, Yerdes E, Elboga U, et al
    The role of 18 F-FDG PET/CT SUVmax values in evaluating treatment response in hormone receptor-positive metastatic breast cancer patients receiving CDK4/6 inhibitor therapy.
    Ann Nucl Med. 2026 May 29. doi: 10.1007/s12149-026-02233.
    PubMed         Abstract available

  2. LOMER NB, Sadeghpour S, Torigian DA
    FDG-PET/CT Parameters for distinguishing high and low microsatellite instability in colorectal cancer: A systematic review and Meta-analysis.
    Ann Nucl Med. 2026 May 29. doi: 10.1007/s12149-026-02240.
    PubMed         Abstract available

  3. OZKAN E, Demir B, Cengiz Seval G, Araz M, et al
    Response to the comment on "[11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma".
    Ann Nucl Med. 2026 May 25. doi: 10.1007/s12149-026-02237.
    PubMed        

  4. HANAFY MM, Kamal RM, Khater SHSA, Kirollus MMG, et al
    Patterns of positron emission mammography uptake by benign and malignant breast lesions: radiopathological correlation with malignant histopathological subtypes, histological grades, and molecular subtypes.
    Ann Nucl Med. 2026 May 25. doi: 10.1007/s12149-026-02234.
    PubMed         Abstract available

  5. MERCIER B, Dreano L, Neveu E, Estrade F, et al
    Baseline PSMA-ligand PET/CT as a predictive biomarker for early progression in metastatic castration-resistant prostate cancer patients undergoing [177Lu]Lu-PSMA-617 radioligand therapy.
    Ann Nucl Med. 2026 May 23. doi: 10.1007/s12149-026-02236.
    PubMed         Abstract available


    Appl Radiat Isot

  6. KESHAVARZ S, Saeedzadeh E, Arabi H, Jenabi-Haghparast E, et al
    Clinically reliable and stable automated segmentation of DLBCL lesions on PET/CT using self-configuring nnU-Net for robust TMTV quantification.
    Appl Radiat Isot. 2026;235:112721.
    PubMed         Abstract available


    J Nucl Cardiol

  7. BARRETO J, Vashist A, Gallegos Kattan C, Stendahl JC, et al
    Blunted Heart Rate Response to Regadenoson Predicts Cardiovascular Risk Beyond Quantitative PET Myocardial Blood Flow.
    J Nucl Cardiol. 2026 May 25:102766. doi: 10.1016/j.nuclcard.2026.102766.
    PubMed         Abstract available


    J Nucl Med

  8. KOO H, Plyku D, Marzella L
    Utility of Preclinical Dosimetry for First-in-Human Studies with PET Drugs Labeled with Common Radionuclides: A Systematic Review of Radiation Dose Estimates.
    J Nucl Med. 2026 May 28:jnumed.125.270487. doi: 10.2967/jnumed.125.270487.
    PubMed         Abstract available

  9. KO GB, Kim KY, Kang SK, Lee J, et al
    First-in-Human Imaging Results of PHAROS: A Versatile High-Resolution TOF/DOI PET Scanner for Brain, Breast, and Extremity Imaging.
    J Nucl Med. 2026 May 28:jnumed.125.271172. doi: 10.2967/jnumed.125.271172.
    PubMed         Abstract available

  10. PENNINCKX S, Delbart W, Mileva M, Kassas M, et al
    Toward Personalized Radiopharmaceutical Therapy: Radiobiologic Insights Compared with External-Beam Radiotherapy.
    J Nucl Med. 2026 May 28:jnumed.125.271564. doi: 10.2967/jnumed.125.271564.
    PubMed         Abstract available

  11. OSBORNE D, Cutler CS, Chaple IF, Ribeiro Pereira PM, et al
    Industry-Academic Collaboration in Nuclear Medicine: Proceedings from the 2024 CMIIT Industry Partners Circle.
    J Nucl Med. 2026 May 28:jnumed.126.272619. doi: 10.2967/jnumed.126.272619.
    PubMed         Abstract available


    Lancet

  12. POVALA G, Bellaver B, Lussier FZ, Amaral L, et al
    Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study.
    Lancet. 2026;407:2217-2226.
    PubMed         Abstract available

  13. THERRIAULT J
    Advancing tau-PET imaging in Alzheimer's disease.
    Lancet. 2026;407:2148-2149.
    PubMed        


    Nucl Med Commun

  14. OZDOEVA D, Bleyen J, Harth A, Van Den Bossche B, et al
    Impact of single photon emission computed tomography/computed tomography bone scintigraphy on the clinical management of patients with recurrent pain post spinal fusion.
    Nucl Med Commun. 2026 May 27. doi: 10.1097/MNM.0000000000002177.
    PubMed         Abstract available

  15. JIN L, Wang X, Song F, Hou J, et al
    Quantitative AV-45 PET imaging for assessing treatment response to lecanemab and deep cervical lymphatic-venous anastomosis in Alzheimer's disease.
    Nucl Med Commun. 2026 May 27. doi: 10.1097/MNM.0000000000002184.
    PubMed         Abstract available

  16. MAHDI RA, Takkar A, Kumar R, Singh H, et al
    Incremental value of whole-body 18F-fluorodeoxyglucose PET/computed tomography in cavernous sinus syndrome: guiding biopsy and improving diagnostic outcome.
    Nucl Med Commun. 2026 May 27. doi: 10.1097/MNM.0000000000002180.
    PubMed         Abstract available

  17. TATCI E, Bozca B, Dizdar K, Cengiz TI, et al
    Fluorine-18 fluorodeoxyglucose PET/computed tomography-based radiomics for predicting risk groups, tumor stage, and capsular and fat tissue invasion in thymomas.
    Nucl Med Commun. 2026 May 25. doi: 10.1097/MNM.0000000000002179.
    PubMed         Abstract available


    Phys Med Biol

  18. LIU X, Marin T, Vafay Eslahi S, Tiss A, et al
    Scan-wise generalized PET denoising with contrastive adversarial learning.
    Phys Med Biol. 2026 May 22. doi: 10.1088/1361-6560/ae7231.
    PubMed         Abstract available


    Semin Nucl Med

  19. ROY A, Abikhzer G, Slart RHJA, Alberini JL, et al
    PET imaging of large-vessel vasculitis: advancements and future trends.
    Semin Nucl Med. 2026 May 26:S0001-2998(26)00094.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum